Gonadotropins in assisted reproductive technology programs: A review

Q3 Medicine
S. Ostrina, O. F. Serova, E. B. Rudakova, E. A. Fedorova
{"title":"Gonadotropins in assisted reproductive technology programs: A review","authors":"S. Ostrina, O. F. Serova, E. B. Rudakova, E. A. Fedorova","doi":"10.26442/20795696.2024.1.202531","DOIUrl":null,"url":null,"abstract":"Reproductive medicine is actively developing, and new methods, drugs, and protocols are being developed and introduced for the treatment of infertility. Assisted reproductive technologies (ART) are the most effective methods. In ART protocols, ovarian stimulation (OS) is based on gonadotropin use. The choice of the starting dose of gonadotropin is a critical factor in the successful OS and the effectiveness of ART programs. The article describes the development history of gonadotropins and provides current data on their use in ART programs. The use of biosimilars of follitropin alfa in OS is discussed, and the effectiveness of its Russian biosimilar is also addressed. \n \n \n \n \nTRANSLATE with x \n \n English \n \n \n \n \n \n \nArabic \nHebrew \nPolish \n \n \nBulgarian \nHindi \nPortuguese \n \n \nCatalan \nHmong Daw \nRomanian \n \n \nChinese Simplified \nHungarian \nRussian \n \n \nChinese Traditional \nIndonesian \nSlovak \n \n \nCzech \nItalian \nSlovenian \n \n \nDanish \nJapanese \nSpanish \n \n \nDutch \nKlingon \nSwedish \n \n \nEnglish \nKorean \nThai \n \n \nEstonian \nLatvian \nTurkish \n \n \nFinnish \nLithuanian \nUkrainian \n \n \nFrench \nMalay \nUrdu \n \n \nGerman \nMaltese \nVietnamese \n \n \nGreek \nNorwegian \nWelsh \n \n \nHaitian Creole \nPersian \n \n \n \n \n \n \n \n \n \n \n \n \nTRANSLATE with \n \n COPY THE URL BELOW \n \n Back \n \n \nEMBED THE SNIPPET BELOW IN YOUR SITE \n \nEnable collaborative features and customize widget: Bing Webmaster Portal \nBack","PeriodicalId":36505,"journal":{"name":"Gynecology","volume":" 19","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26442/20795696.2024.1.202531","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Reproductive medicine is actively developing, and new methods, drugs, and protocols are being developed and introduced for the treatment of infertility. Assisted reproductive technologies (ART) are the most effective methods. In ART protocols, ovarian stimulation (OS) is based on gonadotropin use. The choice of the starting dose of gonadotropin is a critical factor in the successful OS and the effectiveness of ART programs. The article describes the development history of gonadotropins and provides current data on their use in ART programs. The use of biosimilars of follitropin alfa in OS is discussed, and the effectiveness of its Russian biosimilar is also addressed. TRANSLATE with x English Arabic Hebrew Polish Bulgarian Hindi Portuguese Catalan Hmong Daw Romanian Chinese Simplified Hungarian Russian Chinese Traditional Indonesian Slovak Czech Italian Slovenian Danish Japanese Spanish Dutch Klingon Swedish English Korean Thai Estonian Latvian Turkish Finnish Lithuanian Ukrainian French Malay Urdu German Maltese Vietnamese Greek Norwegian Welsh Haitian Creole Persian TRANSLATE with COPY THE URL BELOW Back EMBED THE SNIPPET BELOW IN YOUR SITE Enable collaborative features and customize widget: Bing Webmaster Portal Back
辅助生殖技术项目中的促性腺激素:综述
生殖医学正在积极发展,用于治疗不孕症的新方法、新药物和新方案也在不断开发和引进。辅助生殖技术(ART)是最有效的方法。在 ART 方案中,卵巢刺激(OS)以促性腺激素的使用为基础。促性腺激素起始剂量的选择是 OS 能否成功和 ART 方案是否有效的关键因素。文章介绍了促性腺激素的发展历史,并提供了目前在抗逆转录病毒疗法项目中使用促性腺激素的数据。文章讨论了促性腺激素α生物仿制药在OS中的应用,并探讨了其俄罗斯生物仿制药的有效性。 TRANSLATE with x English 阿拉伯语 希伯来语 波兰语 保加利亚语 印地语 葡萄牙语 加泰罗尼亚语 Hmong Daw 罗马尼亚语 中文简体 匈牙利语 俄语 中文繁体 印尼语 斯洛伐克语 捷克语 意大利语 斯洛文尼亚语 丹麦语 日语 西班牙语 荷兰语 克林贡语 瑞典语 英语 韩语 泰语 爱沙尼亚语 拉脱维亚语 土耳其语 芬兰语 立陶宛语 乌克兰语 法语 马来语 乌尔都语 德语 马尔他语 越南语 希腊语 挪威语 威尔士语 海地克里奥尔语 波斯语 TRANSLATE with COPY THE URL BELOW Back 在您的网站中嵌入下面的 SNIPPET 启用协作功能并自定义 widget:必应网站管理员门户 返回
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Gynecology
Gynecology Medicine-Obstetrics and Gynecology
CiteScore
0.70
自引率
0.00%
发文量
52
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信